4//SEC Filing
WaferGen Bio-systems, Inc. 4
Accession 0001368993-17-000028
CIK 0001368993operating
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 2:31 PM ET
Size
7.6 KB
Accession
0001368993-17-000028
Insider Transaction Report
Form 4
Henighan Michael P
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2017-02-28$7.35/sh−4,001$29,396→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2017-02-28−10,000→ 0 totalExercise: $2.80Exp: 2023-01-22→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Includes 2,667 restricted stock units ("RSUs").
- [F2]Pursuant to the Agreement and Plan of Merger, dated May 12, 2016, by and among WaferGen Bio-systems, Inc., Takara Bio USA Holdings, Inc., Walrus Acquisition Corporation and Takara Bio USA, Inc. (the "Merger Agreement"), (i) each issued and outstanding RSU was automatically vested and converted into the right to receive $7.347126 in cash, without interest, and (ii) each issued and outstanding share of common stock was automatically cancelled and converted into the right to receive $7.347126 in cash, without interest.
- [F3]Pursuant to the Merger Agreement, this option, whether or not then vested, was cancelled in exchange for a cash payment for each share subject to the option equal to the excess of $7.347126 over the per share exercise price of the option.
Documents
Issuer
WaferGen Bio-systems, Inc.
CIK 0001368993
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001368993
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 2:31 PM ET
- Size
- 7.6 KB